These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10672638)

  • 1. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.
    Valjent E; Maldonado R
    Psychopharmacology (Berl); 2000 Jan; 147(4):436-8. PubMed ID: 10672638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol.
    Hutcheson DM; Tzavara ET; Smadja C; Valjent E; Roques BP; Hanoune J; Maldonado R
    Br J Pharmacol; 1998 Dec; 125(7):1567-77. PubMed ID: 9884086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
    Ghozland S; Matthes HW; Simonin F; Filliol D; Kieffer BL; Maldonado R
    J Neurosci; 2002 Feb; 22(3):1146-54. PubMed ID: 11826143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
    Ginsburg BC; Schulze DR; Hruba L; McMahon LR
    J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.
    Järbe TU; Lamb RJ; Liu Q; Makriyannis A
    Eur J Pharmacol; 2003 Apr; 466(1-2):121-7. PubMed ID: 12679148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptors and reward in the rat: a conditioned place preference study.
    Cheer JF; Kendall DA; Marsden CA
    Psychopharmacology (Berl); 2000 Jul; 151(1):25-30. PubMed ID: 10958113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew.
    Darmani NA
    Pharmacol Biochem Behav; 2001; 69(1-2):239-49. PubMed ID: 11420092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH; Fisher J; Martin BR
    Pharmacol Biochem Behav; 2001; 69(1-2):181-8. PubMed ID: 11420084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to the disruptive effects of Delta(9)-THC on learning in rats.
    Delatte MS; Winsauer PJ; Moerschbaecher JM
    Pharmacol Biochem Behav; 2002 Dec; 74(1):129-40. PubMed ID: 12376160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE; Beninger RJ
    Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural and neurochemical effects of combined MDMA and THC administration in mice.
    Robledo P; Trigo JM; Panayi F; de la Torre R; Maldonado R
    Psychopharmacology (Berl); 2007 Dec; 195(2):255-64. PubMed ID: 17684733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent delta-9-tetrahydrocannabinol (THC) exposure fails to affect THC-induced place and taste conditioning in adult male rats.
    Wakeford AG; Flax SM; Pomfrey RL; Riley AL
    Pharmacol Biochem Behav; 2016 Jan; 140():75-81. PubMed ID: 26577749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist.
    Tsou K; Patrick SL; Walker JM
    Eur J Pharmacol; 1995 Jul; 280(3):R13-5. PubMed ID: 8566091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol.
    Economidou D; Mattioli L; Ubaldi M; Lourdusamy A; Soverchia L; Hardiman G; Campolongo P; Cuomo V; Ciccocioppo R
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):73-85. PubMed ID: 17618662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.
    Nava F; Carta G; Colombo G; Gessa GL
    Neuropharmacology; 2001 Sep; 41(3):392-9. PubMed ID: 11522331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
    Tanda G; Loddo P; Di Chiara G
    Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.
    Berrendero F; Maldonado R
    Psychopharmacology (Berl); 2002 Aug; 163(1):111-7. PubMed ID: 12185408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.